Locations:
Search
Reducing uncollectible revenue, financial burden
An old drug shows new promise for a rare childhood cancer
Will we see this major breakthrough in 2019?
Objective risk assessment guides surveillance and treatment
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Modified screening approach produces high detection rate
Careful management of adverse intraoperative events may reduce morbidity and mortality
Advanced radiotherapy in a rare soft-tissue sarcoma
Experience to date highlights need for immunotherapy focus
What's driving tumor progression is the key, says Nima Sharifi, MD
Patients use fewer narcotics than anticipated
Advertisement
Advertisement